-
Galena Biopharma Inc (NASDAQ: GALE) shares
dropped 39.8 percent to $0.843. Galena Biopharma priced its offering with anticipated gross proceeds of $17 million.
-
Acura Pharmaceuticals, Inc. (NASDAQ: ACUR) shares
declined 28.6 percent to $0.928. Acura Pharmaceuticals shares have dropped 36.27 percent over the past 52 weeks, while the
S&P 500 index has gained 23.72 percent in the same period.
-
Second Sight Medical Products Inc (NASDAQ: EYES)
shares fell 22.8 percent to $2.13 after surging 78.06 percent on Tuesday.
-
Real Goods Solar, Inc. (NASDAQ: RGSE)
shares dipped 22.1 percent to $2.22. RGS Energy priced its $6 million public offering of common stock and warrants.
-
SPS Commerce, Inc. (NASDAQ: SPSC) dropped 19.4
percent to $53.460. SPS Commerce posted upbeat Q4 results, but issued a weak forecast for the current quarter. Canaccord
Genuity downgraded SPS Commerce from Buy to Hold.
-
Tidewater Inc. (NYSE: TDW) fell 18.7 percent to
$1.61. Tidewater reported a Q3 loss of $297.7 million on revenue of $129.2 million.
-
DryShips Inc. (NASDAQ: DRYS) declined 16.2
percent to $4.05 following Q4 results. DryShips reported a Q4 loss
of $54.16 per share on revenue of $12.8 million.
-
Orbotech Ltd (NASDAQ: ORBK) dropped 15.6 percent
to $29.30 after the company posted downbeat Q4 results.
-
Concordia International Corp (NASDAQ: CXRX)
shares dropped 13.5 percent to $3.02 after climbing 17.51 percent on Tuesday. TD Securities downgraded Concordia from Hold to
Reduce.
-
FXCM Inc (NASDAQ: FXCM) shares dropped 13 percent
to $3.00 after declining 49.64 percent on Tuesday.
-
Wesco Aircraft Holdings Inc (NYSE: WAIR) fell 12.7
percent to $13.10 after the company posted downbeat quarterly profit.
-
USANA Health Sciences, Inc. (NYSE: USNA) declined
11.6 percent to $55.40. USANA Health reported Q4 GAAP earnings of $0.87 per share on revenue of $252.9 million.
-
Akamai Technologies, Inc. (NASDAQ: AKAM) dropped
11.4 percent to $62.99. Akamai posted upbeat quarterly results. However, investors were rattled by comments made during its
conference call following the report.
-
Coherus Biosciences Inc (NASDAQ: CHRS) shares
declined 11.2 percent to $23.67. Coherus reported an offering of $125 million shares of common stock.
-
Gilead Sciences, Inc. (NASDAQ: GILD) tumbled 9.4
percent to $66.24. Gilead posted upbeat results for its fourth quarter, but issued
disappointing 2017 sales forecast for its hepatitis C drugs.
-
Parsley Energy Inc (NYSE: PE) shares dropped 7.2
percent to $30.94. Parsley Energy priced its 36 million share offering for total gross proceeds of $1.116 billion and announced
plans to acquire Midland Basin properties from Double Eagle Energy for $2.8 billion.
-
Zillow Group, Inc. (NASDAQ: Z) shares fell 7.1
percent to $34.27. Zillow reported Q4 earnings of $0.14 per share on revenue of $227.6 million. The company projects a net loss
of $20.2 million to $40.2 million on revenue of $1.03 billion to $1.05 billion for the full year.
-
Golar LNG Partners LP (NASDAQ: GMLP) shares fell
5.6 percent to $23.17. Golar LNG Partners priced its 4.5 million common unit offering for total gross proceeds of $103.5
million.
-
The Carlyle Group LP (NASDAQ: CG) shares slipped 5
percent to $16.30 after reporting downbeat earnings for its fourth quarter.
-
AMC Entertainment Holdings Inc (NYSE: AMC) fell 4.4
percent to $31.08. AMC Entertainment priced its upsized 19.047 million share offering at $31.50 per share.
Latest Ratings for GALE
Date |
Firm |
Action |
From |
To |
Feb 2017 |
FBR Capital |
Downgrades |
Outperform |
Market Weight |
Feb 2017 |
Maxim Group |
Downgrades |
Buy |
Hold |
Jun 2016 |
Raymond James |
Downgrades |
Outperform |
Market Perform |
View More Analyst Ratings for
GALE
View the Latest Analyst Ratings
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.